silviu itescu wikipedia

Silviu was Director at Diversa, and Director at Zenyth Therapeutics. ", With the strong backing from his family, core investors, the medical community and support of a key group of executives, Mesoblast has been able to sail smoothly. Use our Premium/VIP Service to contact Silviu Itescu by email now. Recent external collaboration on country level. Select key words to follow your clients. Dr Itescu established Angioblast Systems in 2001 with a focus on development and commercialization of novel therapeutic products for the treatment of cardiovascular diseases and vascular disorders. Update the org chart details of Silviu Itescu. All rights reserved | Disclaimer, Web Interface Conceived and Powered By : SCI Knowledge Interlinks. The strength of its results underpinned Mesoblast's ability to successfully enter into a major strategic alliance with global biopharmaceutical company, Cephalon, in December 2010. Thanks for contacting us!

File your clients in folders. BioSpectrum recognized his efforts and awarded him with the BioSpectrum Asia Pacific Bioscience Industry Person of the Year Award for 2011.

Should we be cautious of viewing COVID-19 vaccine as silver bullet? Following this, he relocated to the US for nearly 20 years with the desire to broaden his knowledge base and also to expose himself to different cultures and complementary expertise.

Karen Edward is affiliated with Mesoblast, Inc. Stay informed and up-to-date on your network with RelSci news and business alerting service. It offers personal, premier, business and corporate banking products and services to its customers. Chief Executive Officer and Managing Director -. Research output per year. A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New York and Melbourne with the sole objective of rapid development and commercialization of therapies to treat patients with bone and joint diseases. He was the first person who proved that certain adult stem cells from bone marrow could be used to repair damaged hearts by creating new small capillary vascular networks. Dr. Silviu Itescu has served on the Mesoblast board since the Company’s founding in 2004, was executive director from 2007 and became CEO and managing director in 2011.Prior to founding Mesoblast in 2004, he established an international reputation as a physician-scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation and heart failure. At Mesoblast, Silviu Itescu has 14 colleagues who can be contacted including Donal O'Dwyer (Director), Michael Spooner (Director)… Industry Colleagues. Silviu served as Executive Director at Mesoblast. Learn more about Biotechnology. PROFESSOR, Hudson Institute - The Ritchie Centre; Email silviu.itescu@hudson.org.au; 2004 2017. My extensive work in cardiac transplantation only served to further underline the lack of sufficient meaningful therapies," says Dr Itescu. ", While speaking about the growth of the company and the changing regulatory scenario, Dr Itescu says, "The current challenges for Mesoblast are in executing our late stage clinical programs, to demonstrate that we can use our resources and cash wisely to broaden our product pipeline and to successfully build an international team as part of a global biopharmaceutical company. 1 North Bridge Road,#08-08 High Street Centre, Singapore 179094Tel : +65-63369142Fax : +65-63369145, © 2020 MM Activ Sci-Tech Communications.

cindyandsilviu. Dr Itescu says, "We have also been supported by an experienced and thoughtful Director Leadership group. The same cells were also able to replace bone at the site of fractures and form blood vessels to deliver nutrients and oxygen to the new bone. Other Affiliations.

Do you need to know more about Silviu Itescu? Julien Ng, Dr. By continuing you agree to the use of cookies. Download our data in Excel on your PC.

Overview; Network; Projects (1) Research Output (25) If you made any changes in Pure these will be visible here soon. Here are a few.

Commenting on this, Dr Itescu says, "I was intrigued by biology and I had a strong desire to make a substantial contribution and to help those in need. Chief Financial Officer. Dive into details by clicking on the dots. The products manufactured by the company are used for the treatment of cardiovascular and neurological conditions, diabetes, eye diseases, bone marrow regeneration, bone fractures, cartilage degeneration and musculoskeletal conditions.

Recently, it announced outstanding clinical trial results of its stem cell product, Revascor, in patients with congestive heart failure, an application with multi-billion dollar revenue potential. 9,371 executive movements have been recorded in the last 12 months. Powered by Pure, Scopus & Elsevier Fingerprint Engine™ © 2020 Elsevier B.V. We use cookies to help provide and enhance our service and tailor content. Mesoblast now boasts of a market capitalization of approximately $1.5 billion, and has $280 million cash on hand. Driven by the fascination towards stem cell research, Dr Itescu began to look for more effective ways of restoring damaged tissue, particularly the heart. While working as the head of Transplantation Immunology at Columbia University Medical Center, US, Dr Itescu specialized in the field of immunosuppressant to prevent the rejection of transplanted organs. For each of our 909,910 listed executives. The company's core strategy is based on three focus areas: products to treat cardiovascular and neurodegenerative diseases; intravenously-delivered products to treat a wide range of inflammatory and immune-based conditions including diabetes, lung diseases, and joint diseases; and the company's suite of orthopedic products for repair of bone and cartilage tissues. Understand their industries and their competitors. Dr Itescu acquired worldwide license in 2004 to commercialize orthopedic applications of proprietary adult stem cell technology that was developed by scientists at South Australia's Hanson Institute and Institute of Medical and Veterinary Science and formed a company called Mesoblast by raising funds through IPO at Australian Securities Exchange. Barclays Bank Plc provides commercial banking services. Network Recent external collaboration on country level. View the executives' biographies.

The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. to follow the career of Silviu Itescu. Silviu Itescu. Mesoblast has been aiming to generate a series of high margin, off-the-shelf adult stem cell products that are obtained from a single donor, commercially expanded and frozen, and subsequently used in potentially thousands of unrelated or allogeneic recipients at the time and place of need. Prior.

Learn about your clients' org charts.

Dr Itescu, who is a member of the US President's Council on Bioethics and the US Food and Drug Administration's Biological Response Modifiers Advisory Committee on cell therapy, has guided Mesoblast's growth. At Mesoblast, Silviu Itescu has 14 colleagues who can be contacted including Donal O'Dwyer (Director), Michael Spooner (Director)…. Report an error

Mesoblast's first-rate clinical results along with its strategic alliance with Cephalon, underscores its position as the world's leading stem cell and regenerative medicine company. Novel therapeutic strategies to reduce the burden of chronic heart failure.

Dr Itescu, who was born in Romania, studied in Australia from the age of seven until he completed his masters in medicine at the University of Melbourne. "My area of clinical focus was cardiovascular medicine and the major unmet needs in patients with advanced heart failure and the lack of alternatives available to them. Silviu Itescu. After three unsuccessful trials, for your security. National Health & Medical Research Council (NHMRC), Research output: Contribution to journal › Article › Research › peer-review.

In the Biotechnology industry, Silviu Itescu has 17,497 colleagues in 1,486 companies located in 42 countries.

If you made any changes in Pure these will be visible here soon. Krum, H., Dilley, R., Gilbert, R., Itescu, S., Kelly, D., Liew, D., Reid, C. & Tonkin, A.

15 March 2012 | Influencers | By BioSpectrum Bureau, Dr Silviu Itescu: Pioneer of adult stem cell therapies. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. He says, "The challenges were the high risk associated with a novel platform technology, the uncertainties associated with early stage companies in a difficult commercial situation and the skepticism by investors that a transition of science and clinical medicine to entrepreneurial leadership could be successfully achieved. Obviously persistence, diligence, focus, setting priorities and goals, and retaining an executive group of people; provide the expertise and complementary skills to de-risk outcomes.". A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New York and Melbourne with the sole objective of rapid development and commercialization of therapies to treat patients with bone and joint diseases. Silviu Itescu has a Medical Degree from Monash University and a Specialty Training in Internal Medicine and Immunology/Rheumatology from New York University.

The firm, is increasing the numbers of its new strategic domestic and international institutional investors, and has a growing number of commercial opportunities.

Barclays Bank Plc. In the Biotechnology industry, Silviu Itescu has 17,293 colleagues in 1,472 companies located in 42 countries. Melbourne-based Mesoblast and its subsidiary Angioblast, based in New York, have been working on commercializing adult stem cell-based products for large clinical indications with unmet clinical needs that present long-term sustainable market opportunities. We will get in touch with you shortly.

During his journey as an entrepreneur, Dr Itescu faced many challenges.

Contact the executives through our email platform. Mesoblast Chief Executive Dr. Silviu Itescu said, "There is an urgent need to provide an effective treatment for patients suffering from chronic low back pain due to degenerative disc disease, a population which today accounts for 50% of prescription opioid usage. "We expect successful launch of our products globally within the next few years," concludes Dr Itescu.

Professor. 11/509,002 filed Aug. Know his bio, wiki, net worth, salary, age, married life with wife, Samantha, and son. His global search led him to South Australia's Hanson Institute where scientists had identified adult stem cells with the potential to regenerate heart tissue and to form new blood vesse ls to improve the heart's blood supply. ID:334008, Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis, Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: A controlled double-blind randomised trial, Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds, Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate, A Phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure. 9,226 executive movements have been recorded in the last 12 months. Add private notes.

Valdez Family Crest, Qui A Tué Ronda Morrison, Adam Air Flight 574 Cvr, Do Big Earthquakes Always Occur Early In The Morning, Dracut Police Scanner, Cupid's Chokehold Original, Logitech Wireless Keyboard Not Working K270, Significado De Alce, How To Draw An Angel Realistic, Midsommar Blood Eagle Scene, Ezequiel Garay Injury, Sunfish Sailboat With Motor, Chinese Funeral Customs, Montreal Meltdown 2020 Schedule, Wallace Ford Noi, Yul Kwon Net Worth, Porsche Battery Maintainer Manual, Chipmunk Vs Squirrel, Four Seasons Greek Mythology, Charles Wayne Hendricks Death, Can You Feel A Baby's Heartbeat In The Womb, Finn Mckenna Interview, 700c Men's Kent Roadtech Road Bike Manual, Nitro Pro 9 Crack,

Be the first to comment

Leave a Reply

Your email address will not be published.


*